Electronically monitored medication adherence predicts hospitalization in heart failure patients

Patient Preference and Adherence

Volumn 8, Issue , 2013, Pages 1-13

  Riegel, Barbara ^a,b   Knafl, George J ^c  

^a UNIVERSITY OF PENNSYLVANIA SCHOOL OF NURSING   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Heart failure; Hospitalization; Medication adherence; Outcomes; Patient compliance; Self care

Indexed keywords

HEMOGLOBIN; NITROGEN; UREA;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DRUG DATABASE; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INFORMATION PROCESSING; INFORMATION PROCESSING DEVICE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT MONITORING; PREDICTION; PROCESS DEVELOPMENT; PROSPECTIVE STUDY; RISK FACTOR; VERY ELDERLY; AREA UNDER THE CURVE; COGNITION; COHORT ANALYSIS; DISEASE CLASSIFICATION; ELECTRONIC MEDICAL RECORD; FATIGUE; HEALTH CARE COST; HEART EJECTION FRACTION; HEMOGLOBIN BLOOD LEVEL; NEUROPSYCHOLOGICAL TEST; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SHORT TERM MEMORY; SOCIAL SUPPORT; UREA NITROGEN BLOOD LEVEL;

EID: 84890419739     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S54520     Document Type: Article

References (51)

1. Heidenreich PA, Albert NM, Allen LA, etal. Forecasting the Impact of Heart Failure in the United States: a policy statement From the American Heart Association. Circ Heart Failure. 2013;6(3):606-619.
2. Giamouzis G, Kalogeropoulos A, Georgiopoulou V, etal. Hospitalization epidemic in patients with heart failure: risk factors, risk prediction, knowledge gaps, and future directions. J Card Fail. 2011;17(1): 54-75.
3. Philbin EF, DiSalvo TG. Prediction of hospital readmission for heart failure: development of a simple risk score based on administrative data. J Am Coll Cardiol. 1999;33(6):1560-1566.
4. Krumholz HM, Chen YT, Wang Y, Vaccarino V, Radford MJ, Horwitz RI. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 2000;139(1 Pt 1):72-77.
5. Felker GM, Leimberger JD, Califf RM, etal. Risk stratification after hospitalization for decompensated heart failure. J Card Fail. 2004;10(6):460-466.
6. Pocock SJ, Wang D, Pfeffer MA, etal. Predictors of mortality and morbidity in patients with chronic heart failure. Eur Heart J. 2006;27(1):65-75.
7. Yamokoski LM, Hasselblad V, Moser DK, etal. Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trial. J Card Fail. 2007;13(1):8-13.
8. Keenan PS, Normand SL, Lin Z, etal. An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes. 2008;1(1):29-37.
9. Au AG, McAlister FA, Bakal JA, Ezekowitz J, Kaul P, van Walraven C. Predicting the risk of unplanned readmission or death within 30days of discharge after a heart failure hospitalization. Am Heart J. 2012;164(3):365-372.
10. Coleman CI, Limone B, Sobieraj DM, etal. Dosing frequency and medication adherence in chronic disease. J Manage Care Pharm. 2012;18(7):527-539.
11. Wu JR, Moser DK, Lennie TA, Burkhart PV. Medication adherence in patients who have heart failure: a review of the literature. Nurs Clin North Am. 2008;43(1):133-153; vii-viii.
12. Correia J, Silva FF, Roque C, Vieira H, Providencia LA. Impact of a specialized outpatient heart failure follow-up program on hospitalization frequency and functional status of patients with advanced heart failure. Rev Port Cardiol. 2007;26(4):335-343.
13. Esposito D, Bagchi AD, Verdier JM, Bencio DS, Kim MS. Medicaid beneficiaries with congestive heart failure: association of medication adherence with healthcare use and costs. Am J Manag Care. 2009;15(7):437-445.
14. Fitzgerald AA, Powers JD, Ho PM, etal. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011;17(8):664-669.
15. Ambardekar AV, Fonarow GC, Hernandez AF, Pan W, Yancy CW, Krantz MJ. Characteristics and in-hospital outcomes for nonadherent patients with heart failure: findings from Get With The Guidelines-Heart Failure (GWTG-HF). Am Heart J. 2009;158(4):644-652.
16. Cole JA, Norman H, Weatherby LB, Walker AM. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes. Pharmacotherapy. 2006;26(8):1157-1164.
17. Knafl GJ, Delucchi KL, Bova CA, Fennie KP, Ding K, Williams AB. A systematic approach for analyzing electronically monitored adherence data. In: Ekwall B, Cronquist M, editors. Micro Electro Mechanical Systems (MEMS) Technology, Fabrication Processes and Applications. Hauppauge (NY): Nova Science; 2010:1-66.
18. Knafl GJ, Fennie KP, Bova C, Dieckhaus K, Williams AB. Electronic monitoring device event modelling on an individual-subject basis using adaptive Poisson regression. Stat Med. 2004;23(5):783-801.
19. Wu JR, Moser DK, De Jong MJ, etal. Defining an evidence-based cutpoint for medication adherence in heart failure. Am Heart J. 2009;157(2):285-291.
20. Bova C, Fennie KP, Dieckhaus K, Knafl GJ, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103-110.
21. Knafl GJ, Schoenthaler A, Ogedegbe G. Secondary analysis of electronically monitored medication adherence data for a cohort of hypertensive African-Americans. Patient Prefer Adherence. 2012;6: 207-219.
22. Riegel B, Moelter ST, Ratcliffe SJ, etal. Excessive daytime sleepiness is associated with poor medication adherence in adults with heart failure. J Card Fail. 2011;17(4):340-348.
23. Buckwalter JG, Crooks VC, Petitti DB. A preliminary psychometric analysis of a computer-assisted administration of the Telephone Interview of Cognitive Status-modified. J Clin Exp Neuropsychol. 2002;24(2):168-175.
24. Riegel B, Lee CS, Ratcliffe SJ, etal. Predictors of objectively measured medication nonadherence in adults with heart failure. Circ Heart Fail. 2012;5(4):430-436.
25. Zimet GD, Dahlem NW, Zimet SG, Farley GK. Multidimensional scale of perceived social support. In: Fischer J, Corcoran, K, editors. Measures for Clinical Practice: A Sourcebook. Volume 2-Adults. 2nd ed. New York: Free Press; 1994.
26. Charlson M, Pompei P, Ales K, MacKenzie C. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
27. Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail. 2006;12(1):e1-e2.
28. Riegel B, Lee CS, Dickson VV, Carlson B. An update on the self-care of heart failure index. J Cardiovasc Nurs. 2009;24(6):485-497.
29. van der Wal MH, Jaarsma T, Moser DK, van Veldhuisen DJ. Development and testing of the Dutch Heart Failure Knowledge Scale. Eur J Cardiovasc Nurs. 2005;4(4):273-277.
30. Green CP, Porter CB, Bresnahan DR, Spertus JA. Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. J Am Coll Cardiol. 2000;35(5): 1245-1255.
31. MacLean AW, Fekken GC, Saskin P, Knowles JB. Psychometric evaluation of the Stanford Sleepiness Scale. J Sleep Res. 1992;1(1): 35-39.
32. Johns MW. Reliability and factor analysis of the Epworth Sleepiness Scale. Sleep. 1992;15(4):376-381.
33. Buysse D, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer, DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193-213.
34. Kroenke K, Spitzer R, Williams J. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
35. Lezak M, Howieson D, Lorig D. Neuropsychological Assessment. 4th ed. New York: Oxford University Press; 2004.
36. Dinges D, Powell J. Microcomputer analyses of performance on a portable, simple visual RT task during sustained operations. Behav Res Methods Instrum Comput. 1985;17(6):652-655.
37. McCullagh P, Nelder JB. Generalized Linear Models. Boca Raton (FL): Chapman and Hall/CRC; 1999.
38. Royston P, Altman DG. Regression using fractional polynomials of continuous covariates: parsimonious parametric modeling. Appl Stat. 1994;43(3):429-467.
39. Hosmer DW, Lemeshow S. Applied Logistic Regression. 2nd ed. New York: John Wiley & Sons; 2000.
40. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-530.
41. Michalsen A, Konig G, Thimme W. Preventable causative factors leading to hospital admission with decompensated heart failure. Heart. 1998;80(5):437-441.
42. Pressler SJ. Cognitive functioning and chronic heart failure: a review of the literature (2002-July 2007). J Cardiovasc Nurs. 2008;23(3):239-249.
43. Pressler SJ, Subramanian U, Kareken D, etal. Cognitive deficits in chronic heart failure. Nurs Res. 2010;59(2):127-139.
44. Zogg JB, Woods SP, Sauceda JA, Wiebe JS, Simoni JM. The role of prospective memory in medication adherence: a review of an emerging literature. J Behav Med. 2012;35(1):47-62.
45. Hailpern SM, Melamed ML, Cohen HW, Hostetter TH. Moderate chronic kidney disease and cognitive function in adults 20 to 59 years of age: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol. 2007;18(7):2205-2213.
46. Tsai KT, Chen JH, Wen CJ, etal. Medication adherence among geriatric outpatients prescribed multiple medications. Am J Geriatr Pharmacother. 2012;10(1):61-68.
47. Dickson VV, Buck H, Riegel B. Multiple comorbid conditions challenge heart failure self-care by decreasing self-efficacy. Nurs Res. 2013;62(1):2-9.
48. Pitt B. Male gender, diabetes, COPD, anemia, and creatinine clearance,30mL/min predicted hospitalization after heart failure diagnosis. Ann Intern Med. 2010;152(8):JC4-2, JC4-3.
49. Silverberg DS, Wexler D, Blum M, etal. The correction of anemia in severe resistant heart failure with erythropoietin and intravenous iron prevents the progression of both the heart and the renal failure and markedly reduces hospitalization. Clin Nephrol. 2002;58 Suppl 1:S37-S45.
50. Naci H, de Lissovoy G, Hollenbeak C, etal. Historical clinical and economic consequences of anemia management in patients with end-stage renal disease on dialysis using erythropoietin stimulating agents versus routine blood transfusions: a retrospective cost-effectiveness analysis. J Med Econ. 2012;15(2):293-304.
51. World Health Organization. Adherence to long-term therapies: Evidence for action. Geneva: World Health Organization; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_full_report.pdf. Accessed November 22, 2013.